Treatment of E. coli and klebsiella bacteremia in agranulocytic animals with antiserum to a UDP-gal epimerase-deficient mutant.
D000380:Agranulocytosis / Q000276:immunology*; D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002238:Carbohydrate Epimerases / Q000378:metabolism; D004195:Disease Models, Animal; D004926:Escherichia coli / Q000201:enzymology / Q000276:immunology*; D004927:Escherichia coli Infections / Q000276:immunology / Q000628:therapy*; D005690:Galactose; D005947:Glucose; D007116:Immunization, Passive; D007710:Klebsiella Infections / Q000276:immunology / Q000628:therapy*; D009154:Mutation; D011817:Rabbits; D018805:Sepsis / Q000188:drug therapy / Q000628:therapy*; D014539:Uridine Diphosphate Sugars
D000900:Anti-Bacterial Agents; D014539:Uridine Diphosphate Sugars; D002238:Carbohydrate Epimerases; D005947:Glucose; D005690:Galactose